Carbon News

Bristol Myers Secures Another FDA Go-Ahead For Breyanzi

BMS CAR-T Therapy Wins FDA Approval for Expanded Use

Pfizer Will Charge $3.5M For Its First FDA-Approved Gene Therapy

FDA Greenlights BMS, J&J CAR-T Therapies

Orchard Therapeutics Outlines U.S. Launch Plans For Lenmeldy

U.S. FDA Approves Bristol Myers Squibb’s Breyanzi

U.S. FDA Grants Accelerated Approval For Iovance’s Skin Cancer Therapy

Vertex, CRISPR’s Gene-Editing Therapy Casgevy Wins Early FDA Nod

Carbon Branch Advisory Statement 2 — Claim Payment Integrity

FDA Approves World’s First CRISPR-Based Medicine For Sickle Cell